American Portfolios Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $57.7K | Sell |
|
|||||
|
2022
Q2 | $71.1K | Hold |
|
|||||
|
2022
Q1 | $84.2K | Sell |
|
|||||
|
2021
Q4 | $115K | Sell |
|
|||||
|
2021
Q3 | $173K | Sell |
|
|||||
|
2021
Q2 | $194K | Hold |
|
|||||
|
2021
Q1 | $182K | Buy |
|
|||||
|
2020
Q4 | $192K | Sell |
|
|||||
|
2020
Q3 | $167K | Hold |
|
|||||
|
2020
Q2 | $165K | Sell |
|
|||||
|
2020
Q1 | $123K | Sell |
|
|||||
|
2019
Q4 | $181K | Sell |
|
|||||
|
2019
Q3 | $216K | Sell |
|
|||||
|
2019
Q2 | $245K | Buy |
|
|||||
|
2019
Q1 | $239K | Sell |
|
|||||
|
2018
Q4 | $216K | Sell |
|
|||||
|
2018
Q3 | $370K | Buy |
|
|||||
|
2018
Q2 | $359K | Buy |
|
|||||
|
2018
Q1 | $287K | Sell |
|
|||||
|
2017
Q4 | $237K | Buy |
|